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Several hypotheses have been made about the patho-
genesis of vitiligo, and some of them have con-
sidered a systemic involvement in the course of the
disease. Evidence has been presented on the role of
oxidative stress as the initial event in melanocyte
degeneration. In accordance with this view, we
determined the levels of some antioxidants, i.e.,
superoxide dismutase, catalase, reduced glutathione,
and vitamin E, in erythrocytes and/or peripheral
blood mononuclear cells from patients with active or
stable vitiligo and from a control group of healthy
subjects. In erythrocytes the parameters evaluated
were not signi®cantly different. On the contrary, in
peripheral blood mononuclear cells, superoxide
dismutase activity was increased in both groups of
patients, whereas catalase activity, reduced
glutathione and vitamin E levels were decreased
exclusively in subjects with active disease. The
imbalance of antioxidants was associated with hyper-
production of reactive oxygen species due to a mito-
chondrial impairment as cyclosporin A, an inhibitor
of the permeability transition pores opening, signi®-
cantly reduced the reactive oxygen species produc-
tion. Moreover an alteration of the mitochondrial
transmembrane potential and a higher percentage of
apoptotic cells were observed in active vitiligo
patients. Based on these results, we suggest that, in
vitiligo, mitochondria might be the target of differ-
ent stimuli, such as reactive oxygen species gener-
ation, cytokines production, catecholamine release,
alteration of Ca2+ metabolism, all of which capable
of inducing melanocyte degeneration. Key words:
apoptosis/catalase/oxidative stress. J Invest Dermatol
117:908±913, 2001
T
he pathogenesis of vitiligo has not been completely
clari®ed and even the process of melanocytes
disappearance from involved skin, i.e., necrosis or
apoptosis, is still to be identi®ed (Nordlund and
Ortonne, 1992, 1998). There is evidence suggesting
that vitiligo is a genetic disease with a high degree of familial
segregation, although the molecular aspects have not been
explored. An inherent melanocyte defect has been suggested at
the base of the disease as melanocytes, in depigmented areas, are
absent or functionally inactive and, in normal appearing skin, may
present morphologic abnormalities (Nordlund and Ortonne, 1998).
Nevertheless, alterations of the whole epidermis with vacuolization
of keratinocytes and functional modi®cations of Langerhans cells in
the affected areas have been reported (Nordlund and Ortonne,
1992, 1998). A possible autoimmune mechanism is also suggested
by the presence of autoantibodies against melanocyte antigens in
some patients, the level of which correlates with the evolution of
the disease. Moreover, signi®cant associations with some organ-
speci®c autoimmune disorders have been reported (Naughton et al,
1983; Nordlund and Ortonne, 1998) and skin homing melanocyte-
speci®c cytotoxic T lymphocytes (CTLs) were found in patients
with autoimmune vitiligo, suggesting a role for CTLs in the
disappearance of melanocytes (Ogg et al, 1998). An increase in
catecholamine discharge or synthesis has been associated with
disease activity (Morrone et al, 1992; Cucchi et al, 2000) indicative
of a direct or indirect role of its release in the depigmentation
process.
Recently, an oxidative stress has been suggested to be the initial
pathogenic event in melanocyte degeneration (Schallreuter et al,
1994; Maresca et al, 1997) and evidence has been presented for
H2O2 accumulation in the epidermis of patients with active disease
(Schallreuter et al, 1994, 1999). Defective recycling of tetrahy-
drobiopterin in the phenylalanine hydroxylase reaction has been
reported in vitiligo epidermis (Schallreuter et al, 1994), which
could induce the intracellular production of H2O2 (Schallreuter
et al, 1991, 1999). Moreover, in cultured melanocytes an alteration
of the antioxidant pattern, with a signi®cant reduction of catalase
activity, has been associated with an increased susceptibility to an
external pro-oxidant agent (Maresca et al, 1997), even if catalase
mRNA expression was not modi®ed (Schallreuter et al, 1999).
Therefore, rather than a primary defect, the antioxidant imbalance
seems to be a marker of the intracellular generation of reactive
oxygen species (ROS). In fact, antioxidant patterns of plasma and
erythrocytes are not altered in vitiligo patients (Picardo et al, 1994).
Recently, however, a decrease in the glutathione peroxidase
activity has been reported in erythrocytes of active vitiligo patients
(Schallreuter et al, 1999). In order to evaluate better whether the
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activity of the disease is associated with a systemic oxidative stress,
we measured the antioxidant pattern and the intracellular gener-
ation of ROS in red blood cells and/or peripheral blood
mononuclear cells (PBMC) of patients with vitiligo.
Our ®ndings demonstrate the presence of an imbalance of
antioxidants in the peripheral blood mononuclear cells of active
vitiligo patients, which is correlated to an increased intracellular
ROS production. This imbalance appears to be due to a
mitochondrial impairment.
MATERIALS AND METHODS
Subjects RBC and PBMC were obtained from 40 consecutive
patients with nonsegmental vitiligo (13 males, 27 females, median age
42y, range 18±53; 25 in the active phase and 15 in the stable phase) and
from 40 age- and sex-matched control subjects. The active or stable
phase was de®ned on the basis of the progression or appearance of
lesions in the last 3 mo and on the absence of new lesions or their
progression in the last 6 mo, respectively. In 11 patients (seven active
and four stable phase) thyroiditis with anti-thyreoglobulin autoantibodies
was detected. No signs of autoimmune diseases were found in any other
patient. A positive family history was recorded in about 25% of the
patients (n = 10).
Cells PBMC were isolated by a gradient of Ficoll-Hypaque (Uppsala,
Sweden) (400 3 g for 30 min at room temperature). The PBMC layer
was removed and washed twice with NaCl 0.9% (200 3 g for 15 min at
4°C).
Enzymatic activities RBC and PBMC were lyzed in ipotonic
solution (Tris 0.005 M) on ice for 1 h and centrifuged at 800 3 g for
10 min at 4°C. Hemoglobin concentration was determined by Drabkin's
method (Drabkin's reagent, Sigma, St Louis, MO) and expressed as g per
100 ml of total blood. Protein concentration in PBMC was determined
in the supernatant by Bradford test and expressed as mg per ml.
Superoxide dismutase (SOD) activities were evaluated by
spectrophotometer (Spitz and Oberley, 1989). In this competitive
inhibition assay, superoxide generated by xanthine±xanthine oxidase is
detected by monitoring the reduction of nitroblue tetrazolium at
505 nm. Total SOD activity was measured at pH 7.8 in Tris±HCl 0.2 M
and Cu2+Zn2+ SOD activity was measured at pH 10.2 in Tris±HCl
0.2 M. Standard curve was performed using human SOD (Sigma) at
different concentrations (0.1, 0.25, 0.5, 1, 2 U per ml). One unit of
activity was de®ned as the amount of protein that yields 50% of maximal
inhibition of nitroblue tetrazolium reduction by superoxide. The results
were reported as units of SOD per mg of proteins or units of SOD per
mg of Hb.
Catalase activity was determined by the rate of disappearance of
hydrogen peroxide (10 mM) measured at 240 nm by spectrophotometer
in a phosphate buffer at pH 7.4 (Claiborne, 1985). One unit of catalase
(Cat) is de®ned as the amount of enzyme that degrades 1 mM of H2O2.
The results were reported as units of Cat per mg of proteins or units of
Cat per mg of Hb.
Vitamin E analysis Pellets of PBMC isolated from 15 ml of
heparinized blood were extracted three times in exane/ethanol (3 : 1
vol/vol) with 125 ng of g-tocopherol and 125 ng of d-tocopherol as
internal standards. The extracts were dried under nitrogen ¯ux, treated
with 25 ml of dry pyridine and then directly silylated with 25 ml of N,O-
bis-(trimethyl-silyl)tri¯uoroacetamide containing 1% trimethylchlorsilane
as catalyst. Tocopherols were analyzed by gas chromatography mass
spectrometry with an Ultra 2 column (30 m 3 0.2 mm internal
diameter, 0.25 mm Hewlett Packard, Cupertino, CA) by a selected
ion(s) monitoring technique. The ions selected were 237.277 and 502
for a-tocopherol, 223.263 and 488 for g-tocopherol (Picardo et al,
1996). Analyses were repeated twice in each extract with a difference of
less than 5%.
Reduced glutathione analysis Erythrocytes were lyzed with an equal
volume of cold water in the presence of 50 mM N-ethylmaleimide
(Sigma) on ice for 20 min. Stroma were removed by centrifugation at
14,000 r.p.m. (20,000 g) for 10 min whereas the supernatant was ®ltered
by Microcon-10 membrane at 10,000 r.p.m. (10,000 g) for 5 min and
then analyzed by capillary electrophoresis. PBMC were lyzed in aqueous
solution of N-ethylmaleimide 10 mM on ice for 30 min. Thiosalicylic
Acid (20 mM) (Sigma), as internal standard, and CH3CN (250 ml), to
precipitate the proteins, were added. The ®nal volume was 1 ml. After
centrifugation the supernatant was analyzed by liquid chromatography-
mass spectrometry method (Camera et al, 2001).
ROS detection Intracellular ROS production was detected by 2¢,7¢-
dichloro¯uorescein diacetate (DCFH-DA, Fluka AG, Switzerland), a
substance that is oxidized to ¯uorescent 2¢,7¢-dichloro¯uorescein by
H2O2, other ROS and low molecule weight peroxides produced by the
cells (Wang et al, 1996). PBMC (1 3 106) were incubated at 37°C for
30 min with 2.5 mM DCFH-DA in phosphate-buffered saline with
calcium and magnesium and 5 mM glucose (PBS) and then immediately
analyzed by ¯ow cytometer (Cytoron Absolute, Ortho Diagnostic
Systems, Raritan, NJ, USA, with excitation and emission settings of 488
and 530 nm, respectively). The median of FL-1 channel of ¯uorescence
was used as the parameter to evaluate the intracellular content of ROS
because it matches the maximal number of cells with the highest
¯uorescence.
Mitochondrial transmembrane potential determination JC-1
(5,5¢,6,6¢-tetrachloro-1,1¢,3,3¢-tetraethylbenzimidazolcarbocyanine iodide;
Molecular Probes, Eugene, OR) was dissolved at 2.5 mg per ml in N-
N-dimethylformamide (Merck AG Darmstad, Germany). PBMC were
washed and stained with 2.5 mg per ml of JC-1 for 15 min at 37°C, then
washed in PBS and immediately analyzed by ¯ow cytometer for green
and red ¯uorescences (Cossarizza et al, 1993).
Apoptosis detection After DCFH-DA exposure, PBMC were stained
with 1 ml of Annexin V Cy3 (MBL, Nagoya, Japan) and immediately
analyzed by ¯ow cytometer with emission setting at 570 nm. As
Annexin V binding represents one of the very early events in the
apoptotic process, the differential forward light scatter of living and
apoptotic cells was also used to assess the two populations, and electronic
gates (R1 and R2) were evaluated independently from Annexin V
staining. Decreased forward light scatter in R2 characterizes cells at all
stages of apoptosis, including late ones. Another independent method for
apoptosis detection was also used in 10 patients and 10 controls, i.e.,
propidium iodide assay according to Nicoletti et al (1991). Propidium








Cat (U per mg Hb) 408 6 38.50 385 6 58.5 370 6 61.4
SOD (U per mg Hb) 0.55 6 0.12 0.54 6 0.15 0.56 6 0.15
GSH (nmol per mg Hb) 61.5 6 17 63 6 7.3 67.4 6 16
PBMC
Cat (U per mg protein) 167.17 6 49.01 162.62 6 46.62 134.47 6 33.44a
SOD (U per mg protein) 3.94 6 0.17 5.95 6 0.5 4.65 6 0.05a
CuZnSOD (U per mg protein) 2.011 6 0.03 3.96 6 0.07b 3.24 6 0.016b
MnSOD (U per mg protein) 1.88 6 0.04 2.05 6 0.15 1.44 6 0.12
GSH (nmol per mg protein) 63.6 6 9.7 65 6 8.4 32.8 6 4a
Vitamin E (ng per mg protein) 0.36 6 0.12 0.21 6 0.15 0.18 6 0.16c
ap < 0.001 and bp < 0.05 vs normal subjects; cr = ±0.8 between VitE and MnSOD.
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iodide (Sigma) 1 ml per ml was added to PBMC suspension after
DCFH-DA staining for 20 min and then evaluated by ¯ow cytometry.
Phenotype analysis PBMC were stained 30 min at 4°C with
¯uorochrome conjugated monoclonal antibodies for CD3, CD4, CD8,
CD20, CD45, CD45RA, CD45R0, cutaneous leukocyte antigen (all
from Pharmingen-Becton Dickinson Company, San Diego, CA), washed
in PBS and immediately analyzed by ¯ow cytometer with the gate on
lymphocytes.
Cyclosporin A treatment Cyclosporin A (CsA) (Sigma) was dissolved
in ethanol (stored at ±20°C) and used at 1 mM immediately before any
staining.
Statistical analyses Student's t and Pearson tests were utilized for
statistical analyses.
RESULTS
Antioxidant imbalance in PBMC from patients with active
vitiligo To evaluate whether the antioxidant imbalance during
active vitiligo was systemically detectable, we evaluated SOD and
Cat activity, vitamin E and GSH concentration in RBC and/or
PBMC from patients with active or stable disease. In erythrocytes,
the antioxidants evaluated (GSH, SOD, Cat) were not signi®cantly
different in the patient groups with respect to the values in normal
subjects (Table I). On the contrary, statistically signi®cant
differences were observed with values from PBMC (Table I).
SOD activity, in particular the cytosolic component (Cu2+Zn2+
SOD) was signi®cantly (p < 0.05) increased in both vitiligo groups,
whereas Cat activity was decreased exclusively in the cells of
Figure 1. Hyperproduction of ROS in
PBMC from active vitiligo patients. The ¯ow
cytometric analysis shows a signi®cant higher level
of DCFH-DA median intensity (FL-1 histogram,
top of ®gure) in PBMC from active vitiligo
patients (*p < 0.0001). The graph shows the
mean 6 SD of each group (n = 25 for active
vitiligo; n = 40 for normal; n = 15 for stable
vitiligo; n = 25 for active vitiligo pretreated with
CsA). Pretreatment with CsA (1 mM) signi®cantly
reduces DCFH-DA intensity (**p < 0.001).
Figure 2. Mitochondrial alteration during active phase of disease.
A representative ¯ow cytometric analysis of JC-1 staining indicate a drop
of transmembrane potential in PBMC from active vitiligo patients vs
normal subjects, as indicated by the reduction of JC-1 aggregates.
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subjects with active disease (p < 0.001). Consequently, the U
SOD/U Cat ratio, a parameter of cell susceptibility to oxidative
stress (Moysan et al, 1993), was altered exclusively in the latter
group of patients. GSH level was signi®cantly lower (p < 0.005) in
PBMC from active vitiligo patients and even though a wide range
in the vitamin E concentration was observed (0.08±0.75 mg per mg
protein) in all the groups, the mean concentration in active vitiligo
was lower and inversely correlated with the Mn2+SOD activity
(r = ±0.8) (Table I). The alteration of the antioxidant patterns
detected in PBMC was similar to that previously described in
melanocytes (Maresca et al, 1997), indicating a systemic
involvement during the active phase of the disease. The
observation of a normal antioxidant pattern in the RBC,
however, suggests that the alterations are not a primary defect,
but more likely due to a metabolic process, present in PBMC,
which leads to an enhancement of intracellular ROS production.
Increased ROS generation in active vitiligo PBMC In order
to determine the intracellular ROS production, DCFH-DA
staining (Wang et al, 1996) was performed on PBMC from the
same groups. Flow cytometry analysis showed a signi®cantly higher
level of ¯uorescence in CD45+ cells from active vitiligo subjects (p
< 0.0001) (Fig 1). No signi®cant differences were observed when
lymphocyte subpopulations were evaluated (CD4, CD8, CD45R0,
or CD45RA).
Intracellular hyperproduction of ROS can be the result of the
opening of mitochondrial permeability transition pores (PTP),
which re¯ects in a reduction in the mitochondrial transmembrane
potential (DYm), before the cells show signs of nuclear apoptosis
(chromatin condensation and DNA fragmentation) (Zamzami et al,
1995; Yang and Cortopassi, 1998). PTP opening is controlled by
several physiologic and pharmacologic substances, including CsA, a
speci®c short-term (up to 60 min) inhibitor acting on cyclophilin
D associated with the adenine nucleotide translocator (Broekemeier
and Pfeiffer, 1995). CsA (1 mM) signi®cantly decreased DCFH-DA
staining of PBMC in active vitiligo patients (p < 0.0001),
con®rming that ROS production was in¯uenced upon PTP
opening (Fig 1).
Alteration of mitochondrial transmembrane potential and
apoptosis of PBMC from patients with active vitiligo In
active vitiligo PBMC, a signi®cant drop in the mitochondrial DYm
Figure 3. Apoptosis in vitiligo. A higher
percentage of early apoptotic cells was detected by
Annexin V+ in PBMC from active vitiligo
(8 6 2.8%) vs normal or stable (4 6 2.3%)
subjects (*p < 0.0001). The reduction produced
by CsA was not signi®cant.
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was represented by a decrease in the level of JC-1 aggregates (p
< 0.005) (Fig 2), whereas in the cells from the stable group the
pattern of the ¯uorescence was similar to that observed in PBMC
from normal individuals. Several reports have shown that DYm
disruption and subsequent nuclear apoptosis are strictly connected
and therefore we evaluated the percentage of apoptotic cells using
Annexin V staining and forward light scatter analysis in the same
cell populations (Fig 3). In PBMC from active vitiligo patients the
percentage of Annexin V+ cells represented 8 6 2.8% of events
gated in R1 (living cells) and 30% of those gated in R2 (apoptotic
cells) (Carbonari et al, 1994), whereas in PBMC from stable vitiligo
or normal subjects, the Annexin V+ cells were 4 6 2.3% in R1 and
undetectable in R2 (p < 0.0001).
In active vitiligo patients, the R2 region comprised a higher
number of cells (20% of total acquired event vs 2±4% in normal
subjects and stable subjects). The PBMC Annexin V+ DCFH-DA+
in R1 region, represent cells in an early phase of apoptosis, and
PBMC Annexin V+ DCFH-DA± in R2 presumably cells that have
terminated the apoptotic program. Annexin V+ cells were either
positive or negative for cutaneous leukocyte antigen, indicating that
apoptotic cells did not speci®cally express the skin homing
receptor. A further analysis showed, in a limited group of subjects
(n = 7), a bimodal distribution of the ¯uorescence intensity for
DCFH-DA, dim and bright (mean of 140 and 168, respectively).
The bright population was Annexin V+, suggesting that in the early
phase of apoptosis the esterases are more active, as also indicated by
the negativity of DCFH-DA staining in R2. Moreover, the
propidium iodide staining performed in some samples, con®rmed
the increase of the apoptotic process in active vitiligo (27.2 6 11 vs
10.7 6 4 in normal subjects, p < 0.01).
DISCUSSION
The complex of the results reported here demonstrate that, during
the active phase of vitiligo, mitochondrial alterations can be
detected in PBMC, which correlate with an increased ROS
generation, a modi®cation of the transmembrane potential, likely
due to PTP opening, and an imbalance of antioxidant system and
apoptosis. The results also con®rm our previous data on a normal
antioxidant pattern in RBC from patients with vitiligo (Picardo
et al, 1994). These cells, lacking mitochondria, in fact, utilize
different metabolic pathways and show a different sensitivity to
pro-oxidants. Mitochondria are key organelles in the control of
intracellular ROS generation as, under physiological conditions, up
to 5% of the oxygen consumed in the respiratory chain is converted
to ROS (Nohl and Hegner, 1978; Chance et al, 1979; Heales et al,
1999). The kinetics of superoxide production has been measured,
and sites of generation have been proposed in complex I (NADH-
CoQ reductase) and in complex III (ubiquinone-cytochrome c
reductase) (Heales et al, 1999). Superoxide is removed by SOD,
producing hydrogen peroxide, which in turn, under certain
circumstances, reacts with free iron or copper ions, give rise to
the more damaging hydroxyl radical. A variety of mitochondrial
poisons increase mitochondrial superoxide production, which is
associated with apoptosis (Heales et al, 1999).
Free radicals, oxidizing agents, modi®cation of fatty acid pattern
of the mitochondrial membrane, catecholamine release, and some
cytokines, such as TNF-a, or increases in Ca2+ concentrations are
events capable of inducing ROS production from mitochondria,
through PTP opening and alteration of the electron transport. Most
of these events have been previously reported as occurring in the
active phase of vitiligo (Naughton et al, 1983; Schallreuter et al,
1994; Ogg et al, 1998). ROS production can lead to an alteration of
the cellular redox state with oxidation of GSH and a decrease of the
catalase activity, whereas the increase of cytoplasmic SOD activity
can be a compensatory mechanism. Moreover, stimuli, such as pro-
oxidants and cytokines, which are capable of reducing mitochon-
drial GSH or vitamin E levels can also induce alteration of the
electron transport in susceptible cells.
Mitochondria ± depending on cell type ± display a different
threshold sensitivity to pro-oxidants (75% to 25%) before inhibition
of ATP synthesis occurs (Heales et al, 1999). High levels of
polyunsaturated fatty acid at the cell membrane and low level of
antioxidants, such as those present in melanocytes, are though to be
responsible for a higher susceptibility to pro-oxidant agents (Yohn
et al, 1991; Maresca et al, 1997; Cucchi et al 2000). Notably,
vitiligo vulgaris has been described in the course of mitochondrial
diseases, such as mitochondrial myopathy, encephalopathy, lactic
acidosis and stroke like episodes (MELAS) syndrome and some
cases have been reported in ataxia telangiectasia (Cohen et al, 1984;
Taieb, 2000).
In conclusion, our results suggests that a mechanism involving
different cell types is acting during the active phase of the disease
(Naughton et al, 1983; Nordlund and Ortonne, 1992, 1998; Ogg
et al, 1998). Given that several mechanisms are though to be at the
basis of the pathogenesis of vitiligo, and that a ``convergence
theory'' has been proposed (Le Poole et al, 1993), the mitochon-
drial dysfunction observed here could represent the possible target
of different stimuli and the biochemical basis for the insurgence of
the disease.
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